SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17122430
Source:
http://linkedlifedata.com/resource/pubmed/id/17122430
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0010181
,
umls-concept:C0032143
,
umls-concept:C0205178
,
umls-concept:C0348016
,
umls-concept:C0520997
,
umls-concept:C0557702
,
umls-concept:C0948008
pubmed:issue
1
pubmed:dateCreated
2006-12-25
pubmed:abstractText
The aim of this study was to assess the costs and cost-effectiveness of intravenous thrombolysis treatment with alteplase (Actilyse) of acute ischemic stroke with 24-hour in-house neurology coverage and use of magnetic resonance imaging.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0235266
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1524-4628
pubmed:author
pubmed-author:AndersenGretheG
,
pubmed-author:BechMereteM
,
pubmed-author:ClausenLone BeltoftLB
,
pubmed-author:EhlersLarsL
,
pubmed-author:KjølbyMetteM
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
85-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17122430-Acute Disease
,
pubmed-meshheading:17122430-Brain Ischemia
,
pubmed-meshheading:17122430-Clinical Protocols
,
pubmed-meshheading:17122430-Cost-Benefit Analysis
,
pubmed-meshheading:17122430-Decision Trees
,
pubmed-meshheading:17122430-Denmark
,
pubmed-meshheading:17122430-Fibrinolytic Agents
,
pubmed-meshheading:17122430-Health Care Costs
,
pubmed-meshheading:17122430-Humans
,
pubmed-meshheading:17122430-Infusions, Intravenous
,
pubmed-meshheading:17122430-Magnetic Resonance Imaging
,
pubmed-meshheading:17122430-Markov Chains
,
pubmed-meshheading:17122430-Models, Econometric
,
pubmed-meshheading:17122430-Monte Carlo Method
,
pubmed-meshheading:17122430-Patient Selection
,
pubmed-meshheading:17122430-Predictive Value of Tests
,
pubmed-meshheading:17122430-Preoperative Care
,
pubmed-meshheading:17122430-Quality-Adjusted Life Years
,
pubmed-meshheading:17122430-Stroke
,
pubmed-meshheading:17122430-Thrombolytic Therapy
,
pubmed-meshheading:17122430-Time
,
pubmed-meshheading:17122430-Time Factors
,
pubmed-meshheading:17122430-Tissue Plasminogen Activator
,
pubmed-meshheading:17122430-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
pubmed:affiliation
HTA Unit, Aarhus University Hospital, Olof Palmes Allé 17, 8200 Aarhus N, Denmark. le@ag.aaa.dk
pubmed:publicationType
Journal Article